These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7877232)

  • 1. Inhibition of platelet deposition by combined hirulog and aspirin in a rat carotid endarterectomy model.
    Hamelink JK; Tang DB; Barr CF; Jackson MR; Reid TJ; Gomez ER; Alving BM
    J Vasc Surg; 1995 Mar; 21(3):492-8. PubMed ID: 7877232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic effects of hirulog in a rat carotid endarterectomy model.
    Jackson MR; Reid TJ; Tang DB; O'Donnell SD; Gomez ER; Alving BM
    J Surg Res; 1996 Jan; 60(1):15-22. PubMed ID: 8592407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
    Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery disease.
    Cannon CP; Maraganore JM; Loscalzo J; McAllister A; Eddings K; George D; Selwyn AP; Adelman B; Fox I; Braunwald E
    Am J Cardiol; 1993 Apr; 71(10):778-82. PubMed ID: 8456753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction.
    Théroux P; Pérez-Villa F; Waters D; Lespérance J; Shabani F; Bonan R
    Circulation; 1995 Apr; 91(8):2132-9. PubMed ID: 7697841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hirulog-1 reduces expression of platelet-derived growth factor in neointima of rat carotid artery induced by balloon catheter injury.
    Xue M; Fenton JW; Shen GX
    J Vasc Res; 2000; 37(2):82-92. PubMed ID: 10754393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators.
    White HD; Aylward PE; Frey MJ; Adgey AA; Nair R; Hillis WS; Shalev Y; Brown MA; French JK; Collins R; Maraganore J; Adelman B
    Circulation; 1997 Oct; 96(7):2155-61. PubMed ID: 9337184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial experience with a direct antithrombin, Hirulog, in unstable angina. Anticoagulant, antithrombotic, and clinical effects.
    Lidón RM; Théroux P; Juneau M; Adelman B; Maraganore J
    Circulation; 1993 Oct; 88(4 Pt 1):1495-501. PubMed ID: 8403297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant activity of Hirulog, a direct thrombin inhibitor, in humans.
    Fox I; Dawson A; Loynds P; Eisner J; Findlen K; Levin E; Hanson D; Mant T; Wagner J; Maraganore J
    Thromb Haemost; 1993 Feb; 69(2):157-63. PubMed ID: 8456428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hirulog in the treatment of unstable angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial.
    Fuchs J; Cannon CP
    Circulation; 1995 Aug; 92(4):727-33. PubMed ID: 7641350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective use of BCH-2763, a new potent injectable direct thrombin inhibitor, in combination with tissue plasminogen activator (tPA) in a rat arterial thrombolysis model.
    Deschênes I; Finkle CD; Winocour PD
    Thromb Haemost; 1998 Jul; 80(1):186-91. PubMed ID: 9684808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty.
    Topol EJ; Bonan R; Jewitt D; Sigwart U; Kakkar VV; Rothman M; de Bono D; Ferguson J; Willerson JT; Strony J
    Circulation; 1993 May; 87(5):1622-9. PubMed ID: 8491018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hirulog-like peptide reduces balloon catheter injury induced neointima formation in rat carotid artery without increase in bleeding tendency.
    Xue M; Ren S; Welch S; Shen GX
    J Vasc Res; 2001; 38(2):144-52. PubMed ID: 11316950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
    Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH
    Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin inhibitors and anti-coagulants on thrombin-induced embolisation in rabbit cranial vasculature.
    Liu JT; Paul W; Emerson M; Cicala C; Page CP
    Eur J Pharmacol; 1994 Oct; 264(2):183-90. PubMed ID: 7851481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin: comparison with heparin and aspirin.
    Meyer BJ; Badimon JJ; Chesebro JH; Fallon JT; Fuster V; Badimon L
    Circulation; 1998 Feb; 97(7):681-5. PubMed ID: 9495304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hirudin: clinical potential of a thrombin inhibitor.
    Johnson PH
    Annu Rev Med; 1994; 45():165-77. PubMed ID: 8198374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-clinical and clinical studies on Hirulog: a potent and specific direct thrombin inhibitor.
    Maraganore JM
    Adv Exp Med Biol; 1993; 340():227-36. PubMed ID: 8154339
    [No Abstract]   [Full Text] [Related]  

  • 20. Sustained-release local hirulog therapy decreases early thrombosis but not neointimal thickening after arterial stenting.
    Muller DW; Gordon D; Topol EJ; Levy RJ; Golomb G
    Am Heart J; 1996 Feb; 131(2):211-8. PubMed ID: 8579010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.